Search

Author/Creator Habersetzer, F.

1. Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study. Issue 12 (17th April 2018)

Authors:
Anty, R.; Favre, G.; Coilly, A.; Rossignol, E.; Houssel‐Debry, P.; Duvoux, C.; De Ledinghen, V.; Di Martino, V.; Leroy, V.; Radenne, S.; Kamar, N.; Canva, V.; D'Alteroche, L.; Durand, F.; Dumortier, J.; Lebray, P.; Besch, C.; Tran, A.; Canivet, C. M.; Botta‐Fridlund, D.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 12(2018)
Page Start:
1682
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE). (3rd August 2019)

Authors:
Moehler, M.; Heo, J.; Lee, H.C.; Tak, W.Y.; Chao, Y.; Paik, S.W.; Yim, H.J.; Byun, K.S.; Baron, A.; Ungerechts, G.; Jonker, D.; Ruo, L.; Cho, M.; Kaubisch, A.; Wege, H.; Merle, P.; Ebert, O.; Habersetzer, F.; Blanc, J.F.; Rosmorduc, Olivier
Journal:
Oncoimmunology
Issue:
Volume 8:Number 8(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search